| Dr Alexander P Knapik, MD | |
|
703 Riverway Pl, Bedford, NH 03110-6745 | |
| (603) 627-1661 | |
| (603) 669-6944 |
| Full Name | Dr Alexander P Knapik |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 20 Years |
| Location | 703 Riverway Pl, Bedford, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710128756 | NPI | - | NPPES |
| 1710128756 | Medicaid | MT | |
| AK82089 | Medicaid | RI |
| Facility Name | Location | Facility Type |
|---|---|---|
| Elliot Hospital | Manchester, NH | Hospital |
| Southern Nh Medical Center | Nashua, NH | Hospital |
| Catholic Medical Center | Manchester, NH | Hospital |
| Monadnock Community Hospital | Peterborough, NH | Hospital |
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern New Hampshire Radiology Consultants Pc | 2769436088 | 25 |
| Southern New Hampshire Radiology Consultants Pc | 2769436088 | 25 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
Ten out of 11 patients with severe Tourette's Syndrome have reported improvement after receiving deep brain stimulation surgery, according to University of New South Wales research published in the American Journal of Psychiatry.
The National Institute on Drug Abuse has agreed to award $2.1 million to Lidong Qin, Ph.D., and Ping Wang, Ph.D., of the Houston Methodist Research Institute to develop a pocket-sized drug test for use in health care settings.
Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.
› Verified 8 days ago
| Entity Name | Southern New Hampshire Radiology Consultants Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780648915 PECOS PAC ID: 2769436088 Enrollment ID: O20220324000836 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
Ten out of 11 patients with severe Tourette's Syndrome have reported improvement after receiving deep brain stimulation surgery, according to University of New South Wales research published in the American Journal of Psychiatry.
The National Institute on Drug Abuse has agreed to award $2.1 million to Lidong Qin, Ph.D., and Ping Wang, Ph.D., of the Houston Methodist Research Institute to develop a pocket-sized drug test for use in health care settings.
Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.
› Verified 8 days ago
| Entity Name | Deaconess Intercity Imaging,llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497704860 PECOS PAC ID: 0941238042 Enrollment ID: O20220527000175 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
Ten out of 11 patients with severe Tourette's Syndrome have reported improvement after receiving deep brain stimulation surgery, according to University of New South Wales research published in the American Journal of Psychiatry.
The National Institute on Drug Abuse has agreed to award $2.1 million to Lidong Qin, Ph.D., and Ping Wang, Ph.D., of the Houston Methodist Research Institute to develop a pocket-sized drug test for use in health care settings.
Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.
› Verified 8 days ago
| Entity Name | Intercity Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356390736 PECOS PAC ID: 9830003847 Enrollment ID: O20220527000298 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
Ten out of 11 patients with severe Tourette's Syndrome have reported improvement after receiving deep brain stimulation surgery, according to University of New South Wales research published in the American Journal of Psychiatry.
The National Institute on Drug Abuse has agreed to award $2.1 million to Lidong Qin, Ph.D., and Ping Wang, Ph.D., of the Houston Methodist Research Institute to develop a pocket-sized drug test for use in health care settings.
Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alexander P Knapik, MD 703 Riverway Pl, Bedford, NH 03110-6745 Ph: (603) 627-1661 | Dr Alexander P Knapik, MD 703 Riverway Pl, Bedford, NH 03110-6745 Ph: (603) 627-1661 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.
Ten out of 11 patients with severe Tourette's Syndrome have reported improvement after receiving deep brain stimulation surgery, according to University of New South Wales research published in the American Journal of Psychiatry.
The National Institute on Drug Abuse has agreed to award $2.1 million to Lidong Qin, Ph.D., and Ping Wang, Ph.D., of the Houston Methodist Research Institute to develop a pocket-sized drug test for use in health care settings.
Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.
› Verified 8 days ago
Dr. Joseph K. Azar, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-627-1661 Fax: 603-669-6944 | |
Dr. Wane G Joselow, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-668-7096 Fax: 603-669-6944 | |
Dr. Christopher G Eckel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-668-7096 Fax: 603-669-6944 | |
Dr. Channing S Swan, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-668-7096 Fax: 603-669-6944 | |
David T Wang, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-627-1661 Fax: 603-669-6944 | |
Dr. Robert Remington Sprague, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-627-1661 Fax: 603-669-6944 | |
Dr. Daniel Joseph Sheibley, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 703 Riverway Pl, Bedford, NH 03110 Phone: 603-627-1661 Fax: 603-669-6944 |